Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESOLA DE GRIPE
La disminución de las medidas sanitarias contra la COVID-19, favorece el aumento en el número de casos de enfermedades víricas respiratorias como la gripe, aumentando a su vez, las ventas de productos antigripales, anticatarrales, y para la tos y la faringe.
También crecen las ventas de analgésicos, incluidos en el TOP 10 del mercado de prescripción y en el TOP 2 del segmente OTC (Over The Counter).
MERCADO DE SOLARES
Las farmacias han hecho un reaprovisionamiento de productos solares y del "kit del viajero" (repelentes de insectos, vendas/tiras adhesivas, antidiarreicos…), esperando ver un crecimiento en las ventas como consecuencia de los desplazamientos en Semana Santa.
MERCADO DE PRODUCTOS PARA EL APARATO DIGESTIVO
Los productos relacionados con el aparato digestivo presentan crecimientos positivos y a doble dígito durante este último mes (vs. marzo 2021).
Además, productos antidiarreicos y probióticos se encuentran dentro del TOP 10 clases OTC2 que más han aportado al crecimiento del segmento durante los últimos 12 meses.
Antiácidos, antiulcerosos y antiflatulentos se encuentran también en el TOP 10 ATC2 que más aportan al crecimiento de medicamentos.